(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/crwe_tech.jpg

Your Technology Source, Your Technology Team

Server Maintenance, Web Development, Mobile Application Solutions, SEO Services and more

Contact Us: contact@crwetech.com

www.CRWETech.com

ad2

http://crweworld.com/assets/images/ad/ad4.png

Place Your Ad Here! Advertise your business online on CRWE WORLD. Your Company, product, or service in front of the world!

Contact Us: contact@crweworld.com

www.CRWEWorld.com

ad3

http://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

http://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com

ad5

http://crweworld.com/assets/images/ad/Pathology_Laboratories.png

Quest Diagnostics Inc. (NYSE:DGX) offers the most extensive clinical testing network in the U.S. The Company's extensive test menu includes routine biological testing; complex and specialized molecular and gene-based testing, and anatomic pathology testing. These services primarily help identify disease or risk factors for disease and predict and monitor response to treatment.

www.QuestDiagnostics.com






1722 Result: Health

CorMedix Inc. Reports Update on Neutrolin(R) Phase 3 LOCK-IT 100 Clinical Trial

April 20th, 2017

Bedminster, NJ / CRWE PRESS RELEASE / April 20, 2017 - CorMedix Inc. (NYSE MKT: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,. Read more

Nivalis Therapeutics and Alpine Immune Sciences Agree to Combine

April 18th, 2017

- Plan to Accelerate Development of Novel Immunotherapies Focused on Inflammation and Immuno-Oncology - - Combined Company Well Capitalized with $90 Million in Funding to Advance Discovery and Development - - Existing Investors OrbiMed Advisors. Read more

Abbott and Alere Amend Terms of Merger Agreement

April 16th, 2017

ABBOTT PARK, Ill. and WALTHAM, Mass. / CRWE PRESS RELEASE / April 14, 2017 - Abbott (NYSE: ABT) and Alere Inc. (NYSE: ALR) announced today that the companies have agreed to amend the existing terms of their agreement for Abbott's acquisition of A. Read more

Arbitration Panel Awards Refund to BlackBerry

April 12th, 2017

SAN DIEGO / CRWE PRESS RELEASE / April 12, 2017 - Qualcomm Incorporated (NASDAQ: QCOM) announced a binding interim arbitration award requiring Qualcomm to refund a sum of $814.9 million, plus interest and attorneys’ fees, to BlackBerry Incorpor. Read more

Alere Achieves FDA Clearance for Alere(TM) Reader Platform and Alere BinaxNOW(R) Influenza A & B Card 2

April 11th, 2017

WALTHAM, Mass. / CRWE PRESS RELEASE / April 11, 2017 - Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced that its Alere™ Reader, a diagnostic analyzer that can be used in both point-of-care and laboratory settings, h. Read more

Endeavour Silver Produces 1,076,974 oz Silver and 11,724 oz Gold (1.9 Million oz Silver Equivalents) in the First Quarter, 2017

April 11th, 2017

Vancouver, Canada / CRWE PRESS RELEASE / April 11, 2017 - Endeavour Silver Corp. (TSX: EDR, NYSE: EXK) reports its production results for the First Quarter, 2017 from the Company’s three silver-gold mines in Mexico: the Guanaceví mine in. Read more

Takeda Enters into Strategic Collaboration with NuBiyota for Microbiome Therapeutics

April 11th, 2017

Osaka, Japan / CRWE PRESS RELEASE / April 11, 2017 - Takeda Pharmaceutical Company Limited (TSE:4502) today announced a strategic collaboration with NuBiyota LLC for the development of Microbial Ecosystem Therapeutic products for gastroenterolog. Read more

Qualcomm Files Answer and Counterclaims to Apple Lawsuit

April 11th, 2017

– Highlights Apple’s efforts to devalue the fundamental Qualcomm technologies empowering the iPhone -- SAN DIEGO / CRWE PRESS RELEASE / April 10, 2017 - Qualcomm Incorporated (NASDAQ: QCOM) today filed its Answer and Counterclaims to t. Read more

Barrick Announces Strategic Cooperation Agreement with Shandong Gold

April 06th, 2017

* As a first step, Shandong Gold will acquire 50 percent of the Veladero mine * As a second step, both companies will explore joint development of Pascua-Lama * As a third step, Shandong will evaluate further opportunities with Barrick All amoun. Read more

Puma Biotechnology Launches Expanded Access Program for PB272 (Neratinib) for U.S. Patients with HER2-Positive Breast Cancer or HER2-Mutated Cancer

April 02nd, 2017

Caligor Opco LLC to Provide Regulatory and Logistical Management LOS ANGELES, Calif. / CRWE PRESS RELEASE / April 2, 2017 - Puma Biotechnology, Inc. (Nasdaq: PBYI), a biopharmaceutical company, has initiated an expanded access program (EAP) in the. Read more

Diplomat to Dispense DUPIXENT(R) to Treat Atopic Dermatitis

March 28th, 2017

The nation’s largest independent specialty pharmacy will dispense DUPIXENT® (dupilumab) to treat adults who have moderate-to-severe atopic dermatitis. FLINT, Mich. / CRWE PRESS RELEASE / March 28, 2017 – Diplomat Pharmacy, Inc. (NY. Read more

FDA approves drug to treat Parkinson's disease

March 21st, 2017

Silver Spring, MD / CRWE PRESS RELEASE / March 21, 2017 - The U.S. Food and Drug Administration today approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking levodopa/carbidopa . Read more

Bristol-Myers Squibb and CytomX Therapeutics Extend Worldwide Collaboration to Discover Probody(TM) Therapeutics for the Treatment of Cancer and Other Diseases

March 20th, 2017

* Builds upon initial 2014 alliance in oncology * Includes up to eight additional targets in oncology and other therapeutic areas * CytomX to receive $200 million upfront payment NEW YORK and SOUTH SAN FRANCISCO / CRWE PRESS RELEASE / March 20, . Read more

Hitachi Chemical Signs Agreement to Purchase from Caladrius Biosciences the Remaining 80.1% Interest in PCT for $75 Million

March 16th, 2017

Caladrius expected to emerge as a well-capitalized cell therapeutics-only development company with multiple proprietary technology platforms Conference call begins tomorrow, March 17, 2017 at 8:30 am Eastern time BASKING RIDGE, N.J. / CRWE PRES. Read more

ERF Wireless, Inc. Announces Major Changes to Board of Directors

March 16th, 2017

LEAGUE CITY, Texas / CRWE PRESS RELEASE / March 13, 2017 - ERF WIRELESS, INC. ("ERF") (OTC PINK: ERFB) today announced major changes to its board of directors. Three (3) new directors including Steven M. Sarno, Dr. John B. Barnett, and Joey Milan wer. Read more

Load More Content